Cite
Myasthenic crisis following SARS-CoV-2 infection and delayed virus clearance in a patient treated with rituximab: clinical course and 6-month follow-up
MLA
Markus Reindl, et al. “Myasthenic Crisis Following SARS-CoV-2 Infection and Delayed Virus Clearance in a Patient Treated with Rituximab: Clinical Course and 6-Month Follow-Up.” Journal of Neurology, Nov. 2020. EBSCOhost, https://doi.org/10.1007/s00415-020-10310-x.
APA
Markus Reindl, Judith Löffler-Ragg, Bettina Pfausler, Gerlig Widmann, Florian Deisenhammer, Wolfgang Löscher, Raimund Helbok, Sabina Sahanic, Manuela Kaml, Sophie Wildner, Ronny Beer, & Julia Wanschitz. (2020). Myasthenic crisis following SARS-CoV-2 infection and delayed virus clearance in a patient treated with rituximab: clinical course and 6-month follow-up. Journal of Neurology. https://doi.org/10.1007/s00415-020-10310-x
Chicago
Markus Reindl, Judith Löffler-Ragg, Bettina Pfausler, Gerlig Widmann, Florian Deisenhammer, Wolfgang Löscher, Raimund Helbok, et al. 2020. “Myasthenic Crisis Following SARS-CoV-2 Infection and Delayed Virus Clearance in a Patient Treated with Rituximab: Clinical Course and 6-Month Follow-Up.” Journal of Neurology, November. doi:10.1007/s00415-020-10310-x.